Brenda J. Sousa
Human Resources Officer chez CONSTELLATION PHARMACEUTICALS, INC.
Profil
Brenda J.
Sousa is currently the Director at Career Collaborative, Inc. since 2004 and the Chief Human Resources Officer at Constellation Pharmaceuticals, Inc. since 2010.
Previously, she worked as the Director-Human Resources at RKS Health Ventures Corp.
from 1995 to 1998 and at the Spence Center for Women's Health from 1995 to 1998.
She also held positions as the Vice President-Human Resources & Operations at EPIX Pharmaceuticals, Inc. and as the Vice President-Human Resources at Predix Pharmaceuticals, Inc. Ms. Sousa obtained her undergraduate degree from the University of Massachusetts.
Postes actifs de Brenda J. Sousa
| Sociétés | Poste | Début |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Human Resources Officer | 01/03/2010 |
Career Collaborative, Inc.
 Career Collaborative, Inc. Miscellaneous Commercial ServicesCommercial Services Career Collaborative, Inc. provides social services. The non-profit company is based in Boston, MA. The company was founded by Susan Fox Schiro. Susan P. Yule has been the CEO of the company since 2016. | Director/Board Member | 01/01/2004 |
Anciens postes connus de Brenda J. Sousa
| Sociétés | Poste | Fin |
|---|---|---|
| Spence Center for Women's Health | Human Resources Officer | 01/05/1998 |
| RKS Health Ventures Corp. | Human Resources Officer | 01/05/1998 |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | Human Resources Officer | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Human Resources Officer | - |
Formation de Brenda J. Sousa
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA. | Health Technology |
| RKS Health Ventures Corp. | |
| Spence Center for Women's Health | |
Career Collaborative, Inc.
Career Collaborative, Inc. Miscellaneous Commercial ServicesCommercial Services Career Collaborative, Inc. provides social services. The non-profit company is based in Boston, MA. The company was founded by Susan Fox Schiro. Susan P. Yule has been the CEO of the company since 2016. | Commercial Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
